spacer
IGRAs in the HIV+ Patient: Are We Reaching the Tipping Point?

ANAC2013 Satellite

Saturday, November 23rd - Breakfast
7:00 am - 8:30 am

IGRAs in the HIV+ Patient:  Are we Reaching the Tipping Point?

This Continuing Education symposium will focus on the use of interferon gamma release assays (IGRAs) for the detection of tuberculosis in immunocompromised patients. Through presentation of patient cases and study results, the faculty will present information to see if the weight of evidence supports the use of IGRAs in immunocompromised patients, especially those who are HIV+. Dr. Vinnard and Sara Allen work at the Partnership Comprehensive Care Practice in Center City Philadelphia, one of the largest adult HIV care centers in the region, serving more than 1700 men and women. They have experience using the Tuberculin Skin Test and IGRAs to detect tuberculosis in their patients, and will present cases based on their experience.

Faculty:  Christopher Vinnard, MD, MPH
               Assistant Professor of Medicine
               Division of Infectious Diseases & HIV Medicine
               Drexel University College of Medicine
               Philadelphia, Pennsylvania

               Sara Allen, RN, CRNP, MSN
               Clinical Assistant Professor of Medicine
               Division of Infectious Diseases & HIV Medicine
               Clinic Director
               Partnership Comprehensive Care Clinic
               Philadelphia, Pennsylvania


This program is supported by an educational grant from
Oxford Immunotec


 
Association of Nurses in AIDS Care 3538 Ridgewood Road, Akron, Ohio 44333-3122
tel: 800.260.6780 (toll free) 330.670.0101 (phone) fax: 330.670.0109 email: anac@anacnet.org